Description

Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024

Include: 60 videos + 43 pdfs, size: 22.3 GB
Target Audience: cardiologists, internists, hematologists/oncologists
Sample video: contact me for sample video

Information:

Date & Location

Thursday, May 2, 2024, 8:00 AM – Friday, May 3, 2024, 6:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties

Specialties – Bone Marrow Transplant, Cardiology, Cellular Therapeutics, Critical Care, Emergency Medicine, General and Family Practice, Geriatric Medicine, Hematology, Hospice and Palliative Medicine, Internal Medicine, Leukemia, Lymphoma, Radiation Oncology, Solid Tumor Oncology

Overview

The advances in cancer therapeutics has significantly improved cancer survival. With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher mortality risk due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns about the cardiovascular challenges faced by patients with cancer, the field of Cardio-Oncology has evolved, consisting of experts in both cancer and cardiovascular medicine working to improve the detection, monitoring, and treatment of cardiovascular disease at each stage of the cancer care continuum. The field is rapidly growing to meet the urgent need to improve the cardiovascular health of patients with cancer.

Join us in person in New York City for this state-of-the-art, comprehensive, case-based curriculum addressing critical topics relevant to the cardiovascular health of patients with cancer and cancer survivors. Together, an interdisciplinary group, consisting of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, will present the latest research and contemporary practice strategies in the prevention, early diagnosis, and management of cardiovascular disease in cancer patients and cancer survivors. The symposium will include a series of talks highlighting cutting-edge and trending subjects in the rapidly evolving field of Cardio-Oncology, ensuring that participants gain insights into the most recent advancements shaping the future of cardiovascular care for cancer patients.

This symposium will offer a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 2, 2024, following the symposium, to provide an opportunity for the Cardio-Oncology community to interact and get to know each other. Please RSVP for the networking reception during registration. We hope to see you there!

Who Should Attend

This symposium is intended for cardiologists, internists, hematologists/oncologists, advanced practice providers, nurses, housestaff and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.

Objectives

At the conclusion of this symposium, learners will be able to:

Describe contemporary anti-cancer treatments (such as anthracyclines, targeted therapy, immunotherapy, cellular therapy, radiation), outlining their roles in cancer therapy, mechanisms of action, cardiotoxicity profiles, and their impact on the cardiovascular system
Determine the strategies for monitoring and managing cardiotoxicity, identifying the evidence and the knowledge gaps
Explain the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy
Demonstrate the principles of the permissive cardiotoxicity strategy and how it applies in specific treatment scenarios
Summarize the appropriate use of imaging modalities in contemporary Cardio-Oncology, from guidelines to best practices
State the late cardiovascular sequelae of cancer treatment and the best approach to managing the cardiovascular health of adult survivors of childhood cancer
Illustrate the challenges of managing acute cardiovascular disease in patients during cancer treatment

Topics:

2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..mp4
2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..pdf
5FU Induced Chest Pain- Diagnostic and Management Algorithm.mp4
5FU Induced Chest Pain- Diagnostic and Management Algorithm.pdf
A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.mp4
A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.pdf
Amyloidosis and Multiple Myeloma- Contemporary Diagnosis and New Advances in Treatment Q&A.mp4
Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.mp4
Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.pdf
Best Practices in the Management of Cardiovascular Disease in Patients with Cancer Q&A.mp4
Breast Cancer- Best Practice Strategies to Optimize Outcomes Q&A.mp4
Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.mp4
Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.pdf
Cancer Survivorship and Prevention Q&A.mp4
Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..mp4
Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..pdf
Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.mp4
Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.pdf
Cancer-Associated Stroke- Etiology, Detection and Management.mp4
Cancer-Associated Stroke- Etiology, Detection and Management.pdf
Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.mp4
Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.pdf
Cardio-Oncology- Moving the Field Forward Q&A.mp4
CardioOnc2024_Brochure.pdf
Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.mp4
Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.pdf
Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.mp4
Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.pdf
Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.mp4
Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.pdf
Cardiovascular Considerations in Hematologic Malignancies Q&A.mp4
Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.mp4
Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.pdf
Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.mp4
Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.pdf
Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.mp4
Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.pdf
CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.mp4
CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.pdf
CASE PRESENTATION- ICI Myocarditis Cases from Mild to Deadly.mp4
Common Risk Factors Between Cancer and Cardiovascular Disease.mp4
Common Risk Factors Between Cancer and Cardiovascular Disease.pdf
Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.mp4
Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.pdf
Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..mp4
Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..pdf
Coronary Artery Disease in Cardio-Oncology Q&A.mp4
Developing a Cancer Survivorship Health Care Model.mp4
Electrophysiology in Cardio-Oncology Q&A.mp4
Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.mp4
Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.pdf
How I Use Strain and Biomarkers in My Practice.mp4
How I Use Strain and Biomarkers in My Practice.pdf
How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.mp4
How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.pdf
How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.mp4
How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.pdf
IC-OS- Opportunities for Collaboration, Research, and Education.mp4
IC-OS- Opportunities for Collaboration, Research, and Education.pdf
Immunotherapy- Evolving Landscape in Diagnosing and Managing Immune Related Cardiotoxicity Q&A.mp4
Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.mp4
Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.pdf
Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.mp4
Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.pdf
Lung Cancer- Advances in Treatment and Their Impact on Cardiovascular Health.mp4
Managing Patients with TTR Amyloidosis- Progress and Challenges.mp4
Managing Patients with TTR Amyloidosis- Progress and Challenges.pdf
Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..mp4
Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..pdf
MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.mp4
MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.pdf
Multimodality Imaging – Which Test, When, and Why..mp4
Multimodality Imaging – Which Test, When, and Why..pdf
Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.mp4
Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.pdf
Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.mp4
Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.pdf
Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.mp4
Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.pdf
Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..mp4
Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..pdf
Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..mp4
Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..pdf
Prevention in Cardio-Oncology Q&A.mp4
Prostate Cancer and Cardiovascular Disease Q&A.mp4
Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.mp4
Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.pdf
Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.mp4
Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.pdf
Radiation Therapy and the Heart Q&A.mp4
Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.mp4
Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.pdf
Role of Imaging Markers and Biomarkers in Cardio-Oncology- Strategies for Early Detection of Cardiotoxicity. Q&A.mp4
Striking the Balancing- Navigating Permissive Cardiotoxicity in Cancer Treatment.mp4
The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.mp4
The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.pdf
Thrombosis and Hemostasis in Cancer Q&A.mp4
Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why..pdf
Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why.mp4
Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.mp4
Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.pdf
Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.mp4
Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.pdf